Dow Up0.76% Nasdaq Up0.69%

More On SUNPHARMA.NS

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


Sun Pharmaceutical Industries Limited (SUNPHARMA.NS)

-NSE
810.05 Up 12.70(1.59%) Oct 23, 10:00AM EDT
ProfileGet Profile for:
Sun Pharmaceutical Industries Limited
Acme Plaza
Andheri Kurla Road
Mumbai, 400059
India - Map
Phone: 91 22 6696 9696
Fax: 91 22 2821 2010
Website: http://www.sunpharma.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Biotechnology
Full Time Employees:N/A

Business Summary 

Sun Pharmaceutical Industries Limited, a specialty pharmaceutical company, manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, such as psychiatry, neurology, cardiology, nephrology, gastroenterology, orthopedics, ophthalmology, diabetology, musculo-skeletal and pain, gynecology, and urology, as well as antiasthamatic and antiallergic. It also provides APIs comprising anticancers, peptides, sex hormones, and controlled substances. Sun Pharmaceutical Industries Limited was founded in 1983 and is based in Mumbai, India.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Sun Pharmaceutical Industries Limited

Key Executives 
 PayExercised
Mr. Dilip Shantilal Shanghvi , 58
Managing Director, Exec. Director and Member of Shareholders/Investors Grievance Committee
27.35MN/A
Mr. Sailesh T. Desai , 60
Whole Time Director
9.98MN/A
Mr. Sudhir Vrundavandas Valia , 58
Wholetime Director and Member of Shareholders/Investors Grievance Committee
27.20MN/A
Mr. Uday V. Baldota ,
Chief Financial Officer
N/AN/A
Mr. Ashok I. Bhuta ,
Gen. Mang. of Legal & Secretarial and Compliance Officer
N/AN/A
Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in INR.